avasimibe has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lei, J; Wan, Y; Wang, H; Yin, L; Zhu, D | 1 |
1 other study(ies) available for avasimibe and Breast Neoplasms
Article | Year |
---|---|
Combined effects of avasimibe immunotherapy, doxorubicin chemotherapy, and metal-organic frameworks nanoparticles on breast cancer.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cytotoxicity, Immunologic; Doxorubicin; Drug Carriers; Drug Compounding; Female; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; MCF-7 Cells; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Sulfonamides; T-Lymphocytes, Cytotoxic; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |